— Know what they know.
Not Investment Advice

RPTX NASDAQ

Repare Therapeutics Inc.
1W: +19.8% 1M: +22.1% 3M: +45.2% 1Y: +101.5% 3Y: -82.1% 5Y: -92.2%
$2.65
Last traded 2025-12-31 — delisted
NASDAQ · Healthcare · Biotechnology · $114.2M mcap · 35M float · 3.39% daily turnover · Short 35% of daily vol

📊 Key Metrics

TTM
$12M
Revenue
-82.2% YoY
$-72M
Net Income
+14.1% YoY
$-70M
Free Cash Flow
+9.7% YoY
35.4%
Gross Margin
9.7%
Op. Margin
28.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-49.8%
ROA-43.3%
ROIC-2070.6%

Valuation

P/E-2.6
P/B1.0
EV/EBITDA0.5

Leverage

Debt/Equity0.00
Current Ratio10.71
Interest Cov.0.0x

Quality Scores

Piotroski F3/9
Altman Z-2.07
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms